OpinionPruritic, violaceous papules in a patient with renal cell carcinomaAuthor:Mallory Towe, BS, MSPublish date: June 20, 2024Pembrolizumab was discontinued by oncology because the patient had completed a majority of the cycles of therapy.Read More
